Clinical trial
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction…
NCT00169247 · Groupe Oncologie Radiotherapie Tete et Cou, Other · Completed
Key facts
| NCT number | NCT00169247 |
|---|---|
| Title | Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation |
| Official title | Larynx Preservation With Induction Chemotherapy (Cisplatin, 5FU, Docetaxel) Followed by Radiotherapy Combined With Either Cisplatin or Cetuximab in Laryngopharyngeal Squamous Cell Carcinoma - A Randomised Phase II Study |
| Lead sponsor | Groupe Oncologie Radiotherapie Tete et Cou, Other |
| Collaborators | Tumor Study Group Head and Neck |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Larynx Cancer, Hypopharynx Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cetuximab, Cisplatin, Radiotherapy 70 Gy, 35 fractions |
| Enrollment | 156 |
| Start date | Oct 1, 2005 |
| Primary completion | Apr 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 27, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: